CHICAGO (Reuters) – U.S. officials now say that people 50 and older can get a second COVID-19 booster shot to fortify their immune defenses against COVID-19. But for individuals in that group, the decision is complicated.
WHAT IS THE RECOMMENDATION?
Last month, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention said any person aged 50 and older can get a second COVID-19 booster of an mRNA vaccine from Moderna and Pfizer/BioNTech at least four months following their last shot.
The same goes for people who are severely immunocompromised aged 12 and up as well as those who have received two doses of Johnson & Johnson’s shot.
Dr. Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, said the aim is to give older adults the option to top up waning vaccine protection against severe disease as the virus continues to circulate.
The highly transmissible Omicron BA.2 subvariant has fueled cases in other countries and is now sweeping the United States, accounting for the majority of all coronavirus infections here.